Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
hemohemoFlora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Mélanie Y. Daniel et al. published in Blood Advances:
“Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease”
Title: Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease
Authors: Mélanie Y. Daniel, Antoine Rauch, Camille Paris, Emmanuelle Jeanpierre, Jenny Goudemand, Catherine Marichez, Bénédicte Pradines, Christophe Zawadzki, Annabelle Dupont, Cécile V. Denis, Peter J. Lenting, Sophie Susen, Xavier Delavenne
Read the Full Article on Blood Advances
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Feb 19, 2026, 14:54Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS
-
Feb 19, 2026, 14:41Cansu Kose: Cardiovascular Disease in Women Requires More Than Male-Derived Frameworks
-
Feb 19, 2026, 14:34Favour Kpokpe: Deep Dive Into the Kaggle Stroke Prediction Dataset
-
Feb 19, 2026, 14:28Sam K. Saha: A TIA Is A Warning Shot From A System On The Brink of Failure
-
Feb 19, 2026, 14:23Favour Felix-Ilemhenbhio: Parental Hypoxia Exposure Enhances Offspring Resilience to Stroke
-
Feb 19, 2026, 14:12Bhanu Hima Kumar Gadamsetti: 2018 vs 2026 AHA/ASA Acute Ischemic Stroke Guidelines
-
Feb 19, 2026, 14:10Gonçalo Ferraz Costa: Modern Thrombolytic Strategies and the Risk–Benefit Balance in Valve Thrombosis
-
Feb 19, 2026, 14:07Stéphanie Forté: New Insights on Stroke in Adults with Sickle Cell Disease